See the published version of this preprint at BMC Women's Health.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Research Article
Masoud Bahreini
Bushehr University of Medical Sciences
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background
Breast cancer is one of the most common cancers in Iranian women. They will experience a mental health problem such as depression before, during or after treatment. The aim of this study was to determine the effectiveness of group metacognitive therapy on depression, cognitive emotional regulation, and meta-cognitive beliefs in women with breast cancer.
Methods
in this randomized controlled clinical trial, a total of 24 depressed patients with breast cancer were randomly allocated to experimental and control groups. The experimental group received meta-cognitive therapy in 8 weekly sessions but control group received treatment as usual. Beck's Depression Inventory, cognitive emotion regulation questionnaire, and meta-cognitions questionnaire were completed before, after and one month after intervention. Data were analyzed using Wilcoxon and Chi-square tests.
Results
The mean score of depression in experimental group was reduced from 21.6 ± 4.83 in the pre-test to 13.83 ± 8.12 in one month follow-up (P = 0.16) but there was no significant difference in control group. The mean score of cognitive emotion regulation did not show a significant change in the two groups during the study and follow up period. The mean score of meta-cognitive beliefs was reached 68.75 ± 15.74 from 79.51 ± 10.72 in the experimental group during the follow-up period (P = 0.006), but there was no significant difference in control group in the score of metacognitive beliefs.
Conclusion
These findings support the efficacy of meta-cognitive therapy as a viable psychosocial intervention in depressed patients with breast cancer.
Trial registration
IRCT201606288473N5. Registered on: 05/09/2016
https://www.irct.ir/trial/8946.
Keywords
Breast cancer, depression, cognitive emotion regulation, meta-cognitive therapy, metacognitive beliefs
Figure 1
Figure 1
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at BMC Women's Health.
Version 1
Posted 16 Dec, 2020
No community comments so far
Editorial decision: Major revision
On 01 Feb, 2021
Reviews received
Received 18 Jan, 2021
Reviewers agreed
On 16 Jan, 2021
Reviewers invited
Invitations sent on 18 Dec, 2020
Editor assigned
On 15 Dec, 2020
Editor invited
On 14 Dec, 2020
Submission checks complete
On 14 Dec, 2020
First submitted
On 28 Nov, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
See the published version of this preprint at BMC Women's Health.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research Article
Masoud Bahreini
Bushehr University of Medical Sciences
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at BMC Women's Health.
Version 1
Posted 16 Dec, 2020
No community comments so far
Editorial decision: Major revision
On 01 Feb, 2021
Reviews received
Received 18 Jan, 2021
Reviewers agreed
On 16 Jan, 2021
Reviewers invited
Invitations sent on 18 Dec, 2020
Editor assigned
On 15 Dec, 2020
Editor invited
On 14 Dec, 2020
Submission checks complete
On 14 Dec, 2020
First submitted
On 28 Nov, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at BMC Women's Health.
Background
Breast cancer is one of the most common cancers in Iranian women. They will experience a mental health problem such as depression before, during or after treatment. The aim of this study was to determine the effectiveness of group metacognitive therapy on depression, cognitive emotional regulation, and meta-cognitive beliefs in women with breast cancer.
Methods
in this randomized controlled clinical trial, a total of 24 depressed patients with breast cancer were randomly allocated to experimental and control groups. The experimental group received meta-cognitive therapy in 8 weekly sessions but control group received treatment as usual. Beck's Depression Inventory, cognitive emotion regulation questionnaire, and meta-cognitions questionnaire were completed before, after and one month after intervention. Data were analyzed using Wilcoxon and Chi-square tests.
Results
The mean score of depression in experimental group was reduced from 21.6 ± 4.83 in the pre-test to 13.83 ± 8.12 in one month follow-up (P = 0.16) but there was no significant difference in control group. The mean score of cognitive emotion regulation did not show a significant change in the two groups during the study and follow up period. The mean score of meta-cognitive beliefs was reached 68.75 ± 15.74 from 79.51 ± 10.72 in the experimental group during the follow-up period (P = 0.006), but there was no significant difference in control group in the score of metacognitive beliefs.
Conclusion
These findings support the efficacy of meta-cognitive therapy as a viable psychosocial intervention in depressed patients with breast cancer.
Trial registration
IRCT201606288473N5. Registered on: 05/09/2016
https://www.irct.ir/trial/8946.
Figure 1
Figure 1
This is a list of supplementary files associated with this preprint. Click to download.
Loading...